Use of DNA Purification Kits for Polymerase Chain Reaction Testing of Gen-Probe Chlamydia trachomatis PACE 2 Specimens

Background and Objectives: Confirmation testing using nucleic acid amplification has been shown to improve the sensitivity and specificity of screening tests for Chlamydia trachomatis. However, no critical information on the use of these techniques as an adjunct to Gen-Probe hybridization testing, o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sexually transmitted diseases 1998-05, Vol.25 (5), p.265-271
Hauptverfasser: GOSSACK, JOSEPH P., BEEBE, JAMES L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Objectives: Confirmation testing using nucleic acid amplification has been shown to improve the sensitivity and specificity of screening tests for Chlamydia trachomatis. However, no critical information on the use of these techniques as an adjunct to Gen-Probe hybridization testing, one of the most common screening methods, has been reported to date. We examined the Roche AMPLICOR PCR C. trachomatis Test (Eoche Diagnostic Systems, Branchburg, NJ) as a confirmatory test for the Gen-Probe PACE 2 C. trachomatis Test (San Diego, CA). Further, to mitigate the possible effect of interfering compounds in the Gen-Probe PACE 2 transport medium, we tested various DNA purification techniques. Study Design: C. trachomatis elementary bodies were used to spike PACE 2 Transport medium, which was serially diluted, then tested by polymerase chain reaction (PCR). Six parallel dilution series were conducted; (1) saline dilutions tested by the Syva Direct Specimen Test, (2) Roche AMPLICOE transport medium dilutions tested by PCE, and (3-6) dilutions in PACE 2 transport medium purified respectively by GENECLEANII (BIO101, Vista, CA), Puregene (Gentra Systems, Inc., Eesearch Triangle Park, NC), Microcon 10 (Amicon, Inc., Beverly, MA) DNA isolation kits, and no DNA purification, all tested by PCR. The system giving the best results by in vitro endpoint dilution trials was then used to confirm human specimens previously tested by the Gen-Probe method. Results: PCE detected C. trachomatis at 11 twofold dilutions greater than PACE 2 and equivalent to detection of a single elementary body by Syva Direct Specimen Test. DNA purification of spiked PACE 2 transport medium by the Microcon 100 kit produced the most consistent PCR detection endpoints, equivalent to endpoints of spiked AMPLICOE transport medium. Endpoints with no DNA purification step were variable and lower. Of 78 endocervical specimens negative by PACE 2 and Gen-Probe Probe Competition Assay, 12 (153%) were positive by Microcon DNA purification/PCM testing. Conclusions: PCM can be used as confirmation method for Gen-Probe PACE 2 testing, bet testing must be performed with a DNA purification procedure.
ISSN:0148-5717
1537-4521
DOI:10.1097/00007435-199805000-00009